Molecular Influences Working Memory Circuits in Dorsolateral Prefrontal Cortex

被引:59
作者
Arnsten, Amy F. T. [1 ]
Jin, Lu E. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA
来源
MOLECULAR BASIS OF MEMORY | 2014年 / 122卷
关键词
LOCUS-COERULEUS NEURONS; PROTEIN SIGNALING 4; GUANFACINE EXTENDED-RELEASE; PYRAMIDAL NEURONS; NMDA RECEPTORS; ALPHA-1-ADRENERGIC AGONIST; DOPAMINERGIC INNERVATION; RGS4; POLYMORPHISMS; DENDRITIC SPINES; D1; RECEPTORS;
D O I
10.1016/B978-0-12-420170-5.00008-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The working memory circuits of the primate dorsolateral prefrontal cortex (dlPFC) are modulated in a unique manner, often opposite to the molecular mechanisms needed for long-term memory consolidation. Working memory, our "mental sketch pad" is an ephemeral process, whereby transient, mental representations form the foundation for abstract thought. The microcircuits that generate mental representations are found in deep layer III of the dIPFC, where pyramidal cells excite each other to keep information "in mind" through NMDA receptor synapses on spines. The catecholaminergic and cholinergic arousal systems have rapid and flexible influences on the strength of these connections, thus allowing coordination between arousal and cognitive states. These modulators can rapidly weaken connectivity, for example, as occurs during uncontrollable stress, via feedforward calcium cAMP signaling opening potassium (K+) channels near synapses on spines. Lower levels of calcium cAMP K+ channel signaling provide negative feedback within recurrent excitatory circuits, and help to gate inputs to shape the contents of working memory. There are also explicit mechanisms to inhibit calcium cAMP signaling and strengthen connectivity, for example, postsynaptic (alpha 2A-adrenoceptors on spines. This work has led to the development of the alpha 2A agonist, guanfacine, for the treatment of a variety of dlPFC disorders. In mental illness, there are a variety of genetic insults to the molecules that normally serve to inhibit calcium-cAMP signaling in spines, thus explaining why so many genetic insults can lead to the same phenotype of impaired dlPFC cognitive function. Thus, the molecular mechanisms that provide mental flexibility may also confer vulnerability when dysregulated in cognitive disorders.
引用
收藏
页码:211 / 231
页数:21
相关论文
共 127 条
[1]   Increased prefrontal cortical D1 receptors in drug naive patients with schizophrenia: a PET study with [11C]NNC112 [J].
Abi-Dargham, Anissa ;
Xu, Xiaoyan ;
Thompson, Judy L. ;
Gil, Roberto ;
Kegeles, Lawrence S. ;
Urban, Nina ;
Narendran, Raj ;
Hwang, Dah-Ren ;
Laruelle, Marc ;
Slifstein, Mark .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (06) :794-805
[2]  
[Anonymous], 1987, Handbook Physiol, DOI 10.1002/cphy.cp010509
[3]  
[Anonymous], PSYCHOPATHOLOGY BRAI
[4]   Cumulative Adversity and Smaller Gray Matter Volume in Medial Prefrontal, Anterior Cingulate, and Insula Regions [J].
Ansell, Emily B. ;
Rando, Kenneth ;
Tuit, Keri ;
Guarnaccia, Joseph ;
Sinha, Rajita .
BIOLOGICAL PSYCHIATRY, 2012, 72 (01) :57-64
[5]   Mania: a rational neurobiology [J].
Arnsten, A. F. T. ;
Manji, H. K. .
FUTURE NEUROLOGY, 2008, 3 (02) :125-131
[6]   Through the looking glass: Differential noradenergic modulation of prefrontal cortical function [J].
Arnsten, AFT ;
Simon, F .
NEURAL PLASTICITY, 2000, 7 (1-2) :133-146
[7]   The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys [J].
Arnsten, AFT ;
Jentsch, JD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (01) :55-59
[8]   DOPAMINE D-1 RECEPTOR MECHANISMS IN THE COGNITIVE PERFORMANCE OF YOUNG-ADULT AND AGED MONKEYS [J].
ARNSTEN, AFT ;
CAI, JX ;
MURPHY, BL ;
GOLDMANRAKIC, PS .
PSYCHOPHARMACOLOGY, 1994, 116 (02) :143-151
[9]   Neuromodulation of Thought: Flexibilities and Vulnerabilities in Prefrontal Cortical Network Synapses [J].
Arnsten, Amy F. T. ;
Wang, Min J. ;
Paspalas, Constantinos D. .
NEURON, 2012, 76 (01) :223-239
[10]   The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder [J].
Arnsten, Amy F. T. .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (10) :1595-1605